NCT00003874View on ClinicalTrials.gov

Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

February 28, 1999

Study Completion Date

September 30, 2001

Conditions
LeukemiaLymphoma
Interventions
BIOLOGICAL

monoclonal antibody CD19

BIOLOGICAL

monoclonal antibody CD20

PROCEDURE

in vitro-treated peripheral blood stem cell transplantation

Trial Locations (1)

98109

Fred Hutchinson Cancer Research Center, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER

NCT00003874 - Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia | Biotech Hunter | Biotech Hunter